Wennian Yu
ORCID: 0000-0002-0077-0836
· 1 paper in corpus
preprint
2023
Abstract Objective To investigate the efficacy and safety of dienogest((DNG) monotherapy and gonadotropin-releasing hormone agonist (GnRH-a) combined with DNG sequential treatment for adenomyosis. Methods This is a retrospective study.15…